MacroGenics

discovers, develops, and delivers biologic for the treatment of cancer, autoimmune disorders, and infectious diseases...
Read more
MacroGenics President & CEO: Eric Risser

President & CEO

Eric Risser

CEO Approval Rating

82/100

Annual Revenue
$149.5M
Employees
430
Funding
$348.4M
Acquisitions
1

MacroGenics Competitors

1Endocyte
2Sanofi Genzyme
3Veran
4Ablynx N.V.
5NovImmune
6MSD
7MTEM
8Bridge Medicines
9Ability Biologics
10Amgen

Trending Companies